Current location - Music Encyclopedia - Today in History - Which stocks did COVID-19 test?
Which stocks did COVID-19 test?
Five COVID-19 antigen testing enterprises have been approved in China.

The following three have been listed on the A-share market.

Nuoherui (Science and Technology Innovation Board), Huada Gene (GEM), Wanfu Bio (GEM)

The first echelon: Wanfu Bio; The second echelon: Huada Gene

2. COVID-19 antigen testing enterprises that have been approved to sell abroad.

① It has passed the EU certification.

Oriental Biology, Mingde Biology, Hot Scenery Biology, Shi Shuo Biology, Xu Ansheng Biology, Ke Hua Biology, Yahuilong, mike biological, Botuo Biology, Dean Diagnostics, Daan Gene, Sheng Xiang Biology, New Industries.

Growth Enterprise Market: New Industry, mike biological and Dean Diagnosis.

Motherboard: Daan Gene

② It has obtained American certification.

Jiuan medical treatment

3. Test products in COVID-19

Wei Lan Medicine, Hua Chengsheng, Joey Shenzhou, Berry Gene, Mingde Biology, Yuyue Medical, Saili Medical, Ke Hua Biology, Xilong Science.

The first echelon: Wei Lan Pharmaceutical and Huachengsheng.

The second echelon: Berry Gene, Mingde Bio, Jiu 'an Medical and Saili Medical.

The third echelon: Ke Hua Biology and Xilong Technology.

4. Sales channels for antigen testing

Yifeng Pharmacy, Dashenlin, Yinxintang, common people.

The first echelon: Yifeng Pharmacy

The second echelon: Lin and ordinary people.

5. COVID-19's concept of therapeutic drugs.

China Pharmaceutical, Yiling Pharmaceutical, Cheng Yi Pharmaceutical, Xilong Technology, Xintian Pharmaceutical.

The first echelon: China Medicine.

The second echelon: Yiling Pharmaceutical and Chengyi Pharmaceutical.

6. Raw materials for antigen detection reagents

Beihua, Joy Shenzhou, Guangdong Medical, Hai Shun New Materials, Global Printing.

The first echelon: Beihua shares

The second echelon: Joey Shenzhou, Guangdong Medical and Hai Shun New Materials.